Computational modelling of drug disposition lalitajoshi9
computational modelling of drug disposition is the integral part of computer aided drug design. different kinds of tools being used in the prediction of drug disposition in human body. This topic in the CADD explains the details about the drug disposition, active transporters and tools.
MPH07 Computers in clinical development.pptxBhuminJain1
My topic is computers in clinical development. There are various ways pf collecting data like pure paper based system, electronic based system and communication.
Computational modeling of drug dispositionPV. Viji
Computational modeling of drug disposition , Modeling techniques , Drug absorption , solubility , intestinal permeation , Drug distribution , Drug excretion , Active Transport , P-gp , BCRP , Nucleoside transporters , hPEPT1 , ASBT , OCT , OATP , BBB-choline transporter
review of guidelines for herbal cosmetics by private bodies like cosmos with ...MoidulIslam17
review of guidelines for herbal cosmetics by private bodies like cosmos with respect to preservatives, emollients, foaming agents, emulsifiers and rheology modifiers.
Myself Omkar Tipugade , M- Pharm ,Sem - II, Department of pharmaceutics , from Shree Santkrupa College Of Pharmacy , ghogaon . Today I upload presentation on Active Transport like P-gp , BCPR, Nucleoside transporters etc .
Statistical modeling in pharmaceutical research and development.ANJALI
Statistical modeling in pharmaceutical research and development. This modelling is used in pharmaceutical industries to overcome the challenges related to pharmaceutical formulation, to reduce cost and increase quality and speed of pharmaceutical products.
Video Lecture is available at https://www.youtube.com/watch?v=DXu_CLgB4q0
Introduction, terminology/definitions and rationale, advantages, disadvantages, selection of drug candidates. Approaches to design-controlled release formulations based on diffusion, dissolution and ion exchange principles. Physicochemical and
biological properties of drugs relevant to controlled release formulations.
Computational modelling of drug disposition lalitajoshi9
computational modelling of drug disposition is the integral part of computer aided drug design. different kinds of tools being used in the prediction of drug disposition in human body. This topic in the CADD explains the details about the drug disposition, active transporters and tools.
MPH07 Computers in clinical development.pptxBhuminJain1
My topic is computers in clinical development. There are various ways pf collecting data like pure paper based system, electronic based system and communication.
Computational modeling of drug dispositionPV. Viji
Computational modeling of drug disposition , Modeling techniques , Drug absorption , solubility , intestinal permeation , Drug distribution , Drug excretion , Active Transport , P-gp , BCRP , Nucleoside transporters , hPEPT1 , ASBT , OCT , OATP , BBB-choline transporter
review of guidelines for herbal cosmetics by private bodies like cosmos with ...MoidulIslam17
review of guidelines for herbal cosmetics by private bodies like cosmos with respect to preservatives, emollients, foaming agents, emulsifiers and rheology modifiers.
Myself Omkar Tipugade , M- Pharm ,Sem - II, Department of pharmaceutics , from Shree Santkrupa College Of Pharmacy , ghogaon . Today I upload presentation on Active Transport like P-gp , BCPR, Nucleoside transporters etc .
Statistical modeling in pharmaceutical research and development.ANJALI
Statistical modeling in pharmaceutical research and development. This modelling is used in pharmaceutical industries to overcome the challenges related to pharmaceutical formulation, to reduce cost and increase quality and speed of pharmaceutical products.
Video Lecture is available at https://www.youtube.com/watch?v=DXu_CLgB4q0
Introduction, terminology/definitions and rationale, advantages, disadvantages, selection of drug candidates. Approaches to design-controlled release formulations based on diffusion, dissolution and ion exchange principles. Physicochemical and
biological properties of drugs relevant to controlled release formulations.
Modified-release dosage and its variants are mechanisms used in tablets (pills) and capsules to dissolve a drug over time in order to be released more slowly and steadily into the bloodstream, while having the advantage of being taken at less frequent intervals than immediate-release (IR) formulations of the same drug.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Novel drug delivery system, nanoparticles, resealed erythrocytes, niosomes, microspheres. It also contains information about virus, bacterias and their removal methods and sterility methods.
Powerpoint presentation on controlled drug delivery system. Its introduction, terminologies, rationale, advantages, disadvantages, selection of drug, approaches for designing controlled release formulations and physicochemical and biological properties of drug
Similar to Modified release drug products, Targeted Drug Delivery Systems and Biotechnological Products (20)
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Modified release drug products, Targeted Drug Delivery Systems and Biotechnological Products
1. Presented By,
Mr. Chavan saurav Rajendra
Roll no. 102
First Year M. pharm (Pharmaceutics)
Semester –II
STES’s Smt . Kashibai Navle College of Pharmacy Kondhwa
(BK) Pune -411048
Guided by,
Mrs. Pallavi Chede
(M.Pharm )
Assistant professor
Department of Pharmaceutics
TOPIC
Modified–release drug products, targeted drug delivery systems and
biotechnological products.
1
2. Contents:-
●Introduction
●Variables to consider for modified release dosage Form
●Advantages
●Disadvantages
●Types of modified release oral drug products
●marketed examples
●Targeted drug delivery system
●Need of Targeted drug delivery system
●Ideal characteristics of Targeted drug delivery system
●Advantages Of Targeted drug delivery system
●Disadvantages of Targeted drug delivery system
●various approaches for Targeted drug delivery system
●Biotechnological products
●Case study of Alpress®L.P.
●References
2
3. Introduction:-
●Most conventional (immediate release) oral drug products, such as tablets and capsules,
are formulated to release the active drug immediately after oral administration.
●In the formulation of conventional drug products, no deliberate effort is made to modify
the drug release rate.
● Immediate-release products generally result in relatively rapid drug absorption and
onset of pharmacodynamic effects.
●A modified release drug product refers to a medication that is formulated to release its
active ingredient(s) in a controlled manner over an extended period of time, as opposed to
immediate release formulations that rapidly release the drug upon administration.
●Modified release formulations are designed to optimize drug absorption, maintain
therapeutic drug levels in the body, and reduce the frequency of dosing.
3
4. Variables to consider for modified release dosage form:
1. Low dose
2. Short half life
3. Wide Therapeutic Window
4. Absorbed through the entire GI
5. Modest to rapid absorption
6. Highly stable in the GI
7. Chronic treatment
4
5. Advantages:
1. Increased time within the Therapeutic Window due to lower peak plasma
concentration and shallower slope
2. Reduce dosing frequency
3. Improve patient compliance
4. Reduce gastric irritation and side effects
5. Possible to enhance the bioavailability
6. Alleviate the risk of dose dumping
7. Reduce fluctuation in circulation drug level
8. Avoidance of night time dosing
9. More uniform effect 5
6. Disadvantages:
1. If a toxic dose is given, it will stay toxic for a long time
2. Takes a long time to titrate patient
3. Strong first pass effect by staying below the metabolizing enzymes saturation point
4. Risk of Dose Dumping (failed delivery device) a large immediate dose
5. Inflexible dosing schedule
6. Can't usually split tablets
6
7. Types of modified-release oral drug products :-
1) Extended-release drug products
2) Delayed-release drug products
3) Targeted-release drug products.
4) Orally disintegrating tablets (ODT)
5)Osmotic drug delivery system
7
8. Extended-release drug products:-
This are designed to release the medication into the body over an extended period of
time, providing a sustained and controlled release of the active ingredient. This
allows for less frequent dosing compared to immediate-release formulations. The
extended-release mechanism can be achieved through various technologies, such as
matrix systems, osmotic pumps, or coated beads, which control the drug release
rate.
Delayed-release drug products:-
Delayed-release drug products are designed to release the medication at a specific
time or location in the digestive system, usually to protect the drug from degradation
by stomach acid or to target a specific site in the gastrointestinal tract. These
formulations use enteric coatings or other technologies that resist dissolution in the
acidic environment of the stomach but dissolve or release the drug in the more
alkaline environment of the small intestine.
8
9. Targeted-release drug products:
Targeted-release drug products aim to deliver the medication to a
specific site or tissue within the body. These formulations often utilize
specialized drug delivery systems or carriers that can specifically target
the desired location while minimizing the drug's exposure to other
tissues or organs. Targeted-release systems can be designed for various
routes of administration, such as oral, injectable, or topical.
Orally disintegrating tablets (ODT):
Orally disintegrating tablets, also known as quick-dissolving or fast-
dissolving tablets, are solid dosage forms that rapidly disintegrate or
dissolve in the mouth without the need for water. These tablets are
particularly useful for patients who have difficulty swallowing
conventional tablets or for situations where immediate drug action is
desired. ODTs can be prepared using technologies like lyophilization.
9
10. Osmotic drug delivery system:-
Osmotic drug delivery systems are specialized formulations designed to deliver
drugs in a controlled and predictable manner over an extended period of time. These
systems utilize osmotic pressure as the driving force for drug release. When the
osmotic drug delivery system comes into contact with aqueous fluids, water
permeates through the semi-permeable membrane into the osmotic core due to the
osmotic gradient created by the osmotic agents. As water enters the osmotic core, it
creates pressure that causes the core to expand. This expansion leads to the drug
being pushed out through the delivery orifice at a controlled rate.
10
11. Marketed examples :-
Sr no. Types of modified release
oral drug products
Marketed examples
1) Extended release
1) Sustained release
2) Controlled release
JENBRO-200SR
Flamace CR 200
2) Delayed release Meslataj DR 400mg
3) Target release Proscar®
4) Orally disintegrating
tablet’s
NRZOF-MD
5) Osmotic drug delivery Alpress LP
11
12. Targeted drug delivery system :-
●The conventional drug delivery system involves the absorption of the drug across a
biological membrane, where as the targeted release system releases the drug in a dosage form
at targeted site.
●Targeted drug delivery is a special from of drug delivery system where the medicament is
selectively targeted or delivered only to the site of action and not to the non-targeted organs
or tissues or cells.
●The system is stand on a method that delivers a certain amount of a therapeutic agent for a
prolonged period of time to a targeted diseased area within the body and improves the
efficacy and reduces the side effect.
●This helps maintain the required plasma and tissue drug levels in the body, thereby
preventing any damage to the healthy tissue via the drug.
12
13. ●Carriers used should be biodegradable or readily eliminated from the body without any
problem.
●The preparation of the targeted drug delivery system should be simple, reproductive and
cost effective.
●Targeted drug delivery has high solubility and more drug stability as compare to
conventional drug delivery.
13
15. Ideal characteristics of Targeted drug delivery system:-
●It should be non-toxic and Non-immunogenic.
●It should be physically and chemically stable in vivo and in vitro.
●They control the drug distribution to target cells or tissues or organs.
●Must have uniform capillary distribution.
●Convenient and predicate rate of drug release.
●Drug release does not influence the drug action.
●Carriers used must be bio-degradable or readily eliminated from the body without
any problem and no carrier induced modulation of diseased state.
●The preparation of the delivery system should be easy or reasonably simple,
reproductive and cost effective. 15
16. Advantages of Targeted drug delivery system:-
●Drugs deliver / releases over extended period of time.
●Intermittent dosing can be avoided.
● Improve patient compliance.
●Reduce inter and intra-patient variability.
●Drug can be administered in a smaller dose to produce the desired effect.
● Toxicity is reduced by delivering drug at the targeted site.
● Self administration is possible.
●Enhance absorption of drug.
16
17. Disadvantages of targeted drug delivery system:-
●Requires a skill in manufacturing storage, administration.
●Diffusion and redistribution of drug release
●Rapid clearance of targeted systems.
●Maintaining stability of dosage form is difficult.
●Highly sophisticated technology requires for formulation.
●Expensive.
17
18. Various Approaches for targeted drug delivery system:-
1) Nanoparticals
2) lyposomes
3) Antibody drug conjugets (ADC)
4) microneedles
5) microspheres and microcapsules
18
19. Nanoparticles:-
●Nanoparticles can be engineered to
encapsulate drugs and deliver them to specific
sites in the body.
●They can be made from various materials such
as lipids, polymers, or metals.
●Nanoparticles can be designed to release the
drug payload gradually or in response to
specific stimuli such as changes in pH,
temperature, or enzyme activity.
19
20. Liposome:-
●liposome based targeted drug delivery systems are
a type of drug delivery technology that utilize
liposomes as carriers to transport drugs to specific
target sites in the body.
● Liposomes are artificial vesicles composed of
lipid bilayers, similar to the structure of cell
membranes.
●The main advantage of liposomes as drug carriers
is their ability to encapsulate both hydrophilic
(water-soluble) and hydrophobic (fat-soluble) drugs
within their aqueous core or lipid bilayers,
respectively.
●This flexibility allows liposomes to deliver a wide
range of therapeutic agents, including small
molecules, proteins, nucleic acids, and peptides. 20
21. Antibody-drug conjugates (ADCs) :-
●it is a type of targeted drug delivery system designed
to combine the specificity of antibodies with the
potency of cytotoxic drugs.
●They are engineered molecules that consist of three
main components: an antibody, a linker, and a cytotoxic
drug.
●The antibody component of an ADC is a monoclonal
antibody that specifically recognizes and binds to a
target antigen found on the surface of cancer cells or
other diseased cells.
●The linker is a chemical bridge that connects the
antibody and the cytotoxic drug. It is designed to be
stable in circulation but can be cleaved or degraded
under specific conditions once the ADC reaches its
target site. 21
22. Microneedles:
●Microneedles are tiny needles typically
ranging from hundreds of micrometres to a
few millimetres in length.
●They can be used to painlessly penetrate the
skin and deliver drugs to a specific depth,
allowing targeted delivery to specific tissues
or cells.
●They consist of an array of tiny needles,
which can penetrate the outermost layer of
the skin.
●microneedles have demonstrated great
potential as a promising technology for
targeted drug delivery systems.
22
23. Microspheres and microcapsules:-
●This are important components of targeted drug delivery
systems. They are designed to encapsulate therapeutic
agents, such as drugs or biological molecules, and deliver
them to specific target sites in the body.
●These systems offer several advantages over
conventional drug delivery methods, including controlled
release, improved drug stability, reduced side effects, and
enhanced efficacy.
● Microspheres and microcapsules are spherical particles
with diameters typically ranging from a few micrometres
to several hundred micrometres.
●They can be made from various materials, such as
natural or synthetic polymers, lipids, or proteins.
23
24. Biotechnological products:-
●Biotechnology products means those products that are applicable to the prevention,
treatment, or cure of a disease or condition of human beings and that are produced
using living organisms, materials derived from living organisms, or cellular,
subcellular, or molecular components of living organisms.
●These are those products which are manufactured by recombinant DNA technology
(basically produced by Biotechnology).
●Biotechnology utilizes living organisms or their components to develop products or
processes for various industries, including medicine, agriculture, food production.
●Examples: Antibiotics, vaccines, Genetically Modified Organisms (GMO's),
transgenic plants, beverages etc.
24
25. Genetically Engineered Antibiotics:-
●Biotechnological products have revolutionized the field of
antibiotics by enabling the development of new and more
effective drugs.
●Biotechnology allows scientists to manipulate the genetic
makeup of microorganisms to produce novel antibiotics.
● For example, genetically modified bacteria or fungi can be
designed to produce specific antibiotics in large quantities.
●This approach has led to the development of antibiotics like
vancomycin, which is produced by a genetically engineered
strain of bacteria(Amycolatopsis orientalis).
25
26. Vaccines:-
●Biotechnological products have played a crucial
role in the development and production of
vaccines.
●Vaccines are created to stimulate an immune
response in the body, helping to protect against
specific diseases.
● Biotechnology has provided innovative
techniques and tools that have greatly advanced
the vaccine development process.
●Recombinant DNA technology involves
combining genetic material from different sources
to create novel genetic sequences. This technology
has been used to produce recombinant subunit
vaccines.
26
27. GENETICALLY MODIFIED ORGANISMS (GMO’S):
●A GMO, or genetically modified organism is a plant, animal,microorganism or
other organism whose genetic makeup has been modified in a laboratory using
genetic engineering or transgenic technology.
●This creates combinations of plant, animal, bacterial and virus genes that do not
occur in nature or through traditional crossbreeding methods.
●GMOs have been created for various purposes, including improving crop yield,
enhancing nutritional content, increasing resistance to pests, diseases, or
environmental conditions, and producing pharmaceuticals.
●Types:-
1) Genetically Modified Animals
2) Genetically Modified Bacteria
3)Genetically Modified Plants
4)Genetically Modified Flowers
27
29. Case study of Alpress® L.P.
●product name :- Alpress L.P. 5mg
●Active ingredient :- prazosine
●Manufacturer /marketer:- Pfizer
●The Alpress is a modified release dosage form and comes
under osmotic drug delivery system (ODDS).
●The advantage of the Alpress L.P. system is its ability to
deliver drugs in a controlled manner, ensuring a constant
therapeutic effect and reducing the need for frequent dosing.
●It can be particularly beneficial for drugs that require steady
blood levels or for patients who have difficulty adhering to a
frequent dosing schedule.
●Dosage:-5mg/day
●Special warnings and precautions for use:-
●In order to have its full antihypertensive effect, the prolonged
release prazosin tablet requires the gastrointestinal transit time
to be normal. If the transit time is shortened, the
pharmacokinetic and pharmacodynamic profile may be
changed, reducing the hypertensive efficacy. 29
30. ●Mechanism of action:-
●The Alpress ODDS consists of a drug reservoir, a
semipermeable membrane, and an osmotic engine.
●The drug reservoir contains the medication to be
delivered, while the semipermeable membrane allows for
the passage of water but not the drug molecules.
●The osmotic engine creates a pressure gradient within
the device, driving water into the reservoir through
osmosis.
●As water enters the reservoir, it creates hydrostatic
pressure, which pushes the drug solution out of the system
through a small orifice or delivery port.
●Usage:-Raynaud Disease, Hypertension, Secondary
Hypertension, Benign Prostatic Hyperplasia, Congestive
Heart Failure, Heart Failure.
● adverse effects:- Orthostatic hypotension
●conclusion:-The adverse effects of hypotension may
occur occasionally with ALPRESS LP but there’s is not
require step-wise dose increases or attentive medical
supervision of patients when the treatment is started. 30
31. Reference:-
1)Nalla chandaha, Harish Gopinath, Debjit Bhowmik, wiliamkeri, Thirupathi Reddy
A. Modified release dosage forms.Journal of chemical and pharmaceutical Sciences
Jan- march 2016, Vol 6, page no-13-21.
2) Magoba shivappan, Warkari Rajah.D.,chandrawanshi mayuri I. Bhalekar Rohini
V. viayjendra swamy S.M. A Review on targeted. drug delivery. American Journal
of pharmaceutical research, June 2018, vol4, page no:- 1-11.
3) A. V. Yadav, S. P. Yadav, and R. K. Singh. "Modified-release drug delivery
technology," International Journal of Pharmaceutical Sciences and Research,may
2012. Page no:- 23-34
4) S. S. Patel, D. R. Patel, and M. K. Patel. Recent advances in modified release
drug delivery systems, Journal of Controlled Release, June 2011,Vol 5,page no 81-
99.
5) K. Rani and S. Paliwal, “A review on targeted drug delivery: Its entire focus on
advanced therapeutics and diagnostics,” Scholars Journals of Applied Medical
Sciences, 2014 31
32. 6)Sriharitha, Preethi J, Hemanth Swaroop A Review on Nanoparticles in targeted
drug delivery system Research and Review : Journal of Material Science 2014
7)Priyanka R Kulkarni, Jaydeep D Yadav, Kumar A Vaidya Liposomes: A Novel
Drug Delivery System International Journal of Current Pharmaceutical Research
2011.
8) Brahmankar HA, Jaiswal SB, Biopharmaceutics and Pharmacokinetics A
Treatise, Vallabh Prakashan, 2000, 337, 348-357
9) N. K. Jain Introduction to novel drug delivery systems Vallabh prakashan First
edition 2010 page no 118- 134.
10) https://labeling.pfizer.com/ShowLabeling.aspx?id=15060
32